Table: Hisamitsu -9-MTH group results
Jan 13 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Nov 30, 2016 Nov 30, 2015 Feb 28, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 109.73 122.28 155.00
(-10.3 pct) (+6.4 pct) (-4.2 pct)
Operating 22.00 23.32 28.00
(-5.7 pct) (+49.2 pct) (+1.0 pct)
Recurring 22.89 23.47 29.00
(-2.5 pct) (+3.7 pct) (+3.5 pct)
Net 18.34 15.32 19.40
(+19.7 pct) (+5.8 pct) (+9.1 pct)
EPS 216.23 yen 179.51 yen 228.72 yen
EPS Diluted 216.12 yen 179.49 yen
Ann Div 81.00 yen 81.00 yen
-Q2 div 40.50 yen 40.00 yen
-Q4 div 41.00 yen 40.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO